Rifat Pamukcu
Vermögen: 12 123 $ am 31.07.2026
Vermögen: 12 123 $ am 31.07.2026
Rifat Pamukcu is the founder of Cell Pathways, Inc. Current jobs include Chairman, President & Chief Executive Officer at Midway Pharmaceuticals, Inc. since 2005; President & Chief Executive Officer at Atrin Pharmaceuticals LLC; Chief Executive Officer & Director at RxMP Therapeutics, Inc. since 2016; Director at Virion Therapeutics LLC since 2018; Independent Director at Aprea Therapeutics, Inc. since 2022; Director at Syantra, Inc. since 2019; Director at SIRPant Immunotherapeutics, Inc. since 2021; and Managing Partner at Corami LLC since 2016.
Former job includes Director at Atrin Pharmaceuticals, Inc. Education includes undergraduate studies at The Johns Hopkins University and a doctorate from the University of Wisconsin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
APREA THERAPEUTICS, INC. 0,16 % | 16.06.2026 | 19.554 ( 0,16 % ) | 12 123 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| APREA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2022 |
Midway Pharmaceuticals, Inc.
Midway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops non-antibiotic therapies | Vorstandsvorsitzender | 01.01.2005 |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Vorstandsvorsitzender | - |
RxMP Therapeutics, Inc.
RxMP Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and designs novel hemostatic agents to arrest or prevent excessive bleeding | Vorstandsvorsitzender | 01.01.2016 |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Direktor/Vorstandsmitglied | 01.01.2018 |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Direktor/Vorstandsmitglied | 01.01.2021 |
Corami LLC | Corporate Officer/Principal | 01.01.2016 |
Syantra, Inc.
Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which provides cancer diagnosis services | Direktor/Vorstandsmitglied | 01.01.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
Cell Pathways, Inc.
Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Gründer | 01.01.2003 |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Cell Pathways, Inc.
Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Health Technology |
Midway Pharmaceuticals, Inc.
Midway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops non-antibiotic therapies | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Health Technology |
RxMP Therapeutics, Inc.
RxMP Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and designs novel hemostatic agents to arrest or prevent excessive bleeding | Health Technology |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Health Technology |
Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Syantra, Inc.
Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which provides cancer diagnosis services | Commercial Services |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Health Technology |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Corami LLC |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen